Welcome to Awesome Blog Design perfect blog
Business, Healthcare

Merck presents results from head-to-head Phase 3 KEYNOTE-598 Trial evaluating KEYTRUDA® (pembrolizumab) in combination with ipilimumab versus KEYTRUDA Monotherapy in certain patients with metastatic non-small cell lung cancer

Findings Presented in World Conference on Lung Cancer 2020 Presidential Symposium and Published in the Journal of Clinical Oncology KENILWORTH, N.J. — (BUSINESS WIRE) — $MRK #MRK— Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced first-time data

Business, Technology

Advanced Systems Concepts, Inc. acquires JSCAPE

MORRISTOWN, N.J. — (BUSINESS WIRE) — #ITPprocesses–Advanced Systems Concepts Inc. (ASCI), creators of industry-leading workflow automation software ActiveBatch, today announced that JSCAPE, a managed file transfer (MFT) leader, has been acquired. It will become an important part of ASCI’s product portfolio. JSCAPE

Business, Healthcare

European Commission approves KEYTRUDA® (pembrolizumab) as first-line treatment in adult patients with metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer

KEYTRUDA Is First Checkpoint Inhibitor Approved in Europe to Treat MSI-H or dMMR Colorectal Cancer European Approval Based on Results From KEYNOTE-177 Trial Demonstrating KEYTRUDA Significantly Reduced Risk of Disease Progression or Death by 40% Compared With Chemotherapy KENILWORTH, N.J. — (BUSINESS

Business, Healthcare

AdvanSix furthers commitment to sulfur nutrition

Expands Focus on Sulfur Nutrition for Wide Variety of Crops Including Soybeans Robust Operational Performance Supports Improved Granular Conversion Acquires Certain Assets of Commonwealth Industrial Services (CIS), Adding Packaging, Warehousing and Logistics Capabilities PARSIPPANY, N.J. & HOPEWELL, Va. — (BUSINESS WIRE) —